Perspectives of using angiotensin receptor antagonists

by V V Fomin
Published 2009-06-01

Difficult choice: angiotensin receptor antagonists

by E. O. Taratukhin
Published 2013-04-01

ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES

by E. O. Taratukhin
Published 2013-06-01

NMDA receptor antagonists in the treatment of neurological diseases

by I. S. Preobrazhenskaya
Published 2020-10-01

Metabolic syndrome and angiotensin II receptor antagonists

by K. M. Mamyrbayeva, V. B. Mychka, V. B. Sergienko, I. E. Chazova
Published 2007-04-01

AT II RECEPTOR ANTAGONISTS IN CHRONIC HEART FAILURE TREATMENT

by M. A. Gurevich
Published 2009-04-01

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND NEPHROPROTECTION: PLACE OF OLMESARTAN

by V. V. Fomin
Published 2013-08-01

THE USE OF MINERALOCORTICOID RECEPTOR ANTAGONISTS IN THE PRE VENTION OF ATRIAL FIBRILLATION

by N. T. Vatutin, A. N. Shevelok, G. G. Taradin, I. N. Kravchenko
Published 2019-07-01

Clinical application of mineralocorticoid receptor antagonists in chronic heart failure

by MG Bubnova
Published 2014-12-01

Mineralocorticoid receptor antagonists: new extended roles in cardio- and nephroprotection

by A. M. Esayan, A. N. Nimgirova
Published 2018-04-01

NMDA receptor antagonists in the treatment of patients with vascular cognitive imprairments

by I.S. Preobrazhenskaya
Published 2014-10-01

The benefit of H2 receptors antagonist Rupatadine in treatment for urticaria

by A. A. Kubanov, V. V. Chikin
Published 2017-08-01

The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan

by Galina Anatol'evna Baryshnikova, G A Baryshnikova
Published 2009-03-01

Approaches to therapy for pulmonary hypertension: Role of the endothelin receptor antagonist bosentan

by S N Avdeev
Published 2015-09-01

Use of a nonselective endothelin receptor antagonist in idiopathic pulmonary hypertension

by Ol'ga Aleksandrovna Arkhipova, Tamila Vital'evna Martynyuk, Valentina Kirillovna Lazutkina, Dil'bar Mukumovna Ataullakhanova, Ol'ga Vladimirovna Stukalova, Nikolay Mikhaylovich Danilov, Lyudmila Evgen'evna Samoylenko, Irina Evgen'evna Chazova, O A Arkhipova, T V Martynyuk, V K Lazutkina, D M Ataullakhanova, O V Stukalova, N M Danilov, L E Samoilenko, I E Chazova
Published 2010-11-01

Role of the endothelin receptor antagonist bosentan in the treatment of patients with pulmonary hypertension

by N A Tsareva
Published 2013-12-01

Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia

by A. P. Pereverzev, O. D. Ostroumova, O. N. Tkacheva, Y. V. Kotovskaya
Published 2019-12-01

ENDOTHELIUM RECEPTOR ANTAGONISTS IN PULMONARY ARTERIAL HYPERTENSION: YESTERDAY, TODAY, AND TOMORROW

by T. V. Martynuk, S. N. Nakonechnikov, I. E. Chazova
Published 2009-08-01

Angiotensin II receptor antagonists – we have moved closer to the patient

by L. G. Ratova, I. P. Kolos, I. E. Chazova
Published 2005-04-01

Arterial hypertension and coronary heart disease: the place of angiotensin II receptor antagonists

by E. O. Taratukhin
Published 2012-12-01